Kim et al. found that the deletion of AKT1 resulted in the attenuation of renal fibrosis and tubular dedifferentiation, which proved that AKT1 might serve as a therapeutic target in AKI-to-CKD progression [47]. This evidence concerns the gene AKT1 and renal fibrosis.